LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.18 | 84.90 | 415 | 6963 | 0.0596 | 0.2835 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.18 | 84.90 | 924 | 6963 | 0.1327 | 0.4557 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.88 | 84.90 | 1072 | 7291 | 0.1470 | 0.4840 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.88 | 84.90 | 1116 | 7291 | 0.1531 | 0.4933 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.88 | 84.90 | 442 | 7291 | 0.0606 | 0.2928 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.88 | 84.90 | 976 | 7291 | 0.1339 | 0.4625 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.59 | 84.90 | 1108 | 7641 | 0.1450 | 0.4854 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.59 | 84.90 | 1138 | 7641 | 0.1489 | 0.4915 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.59 | 84.90 | 406 | 7641 | 0.0531 | 0.2726 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.59 | 84.90 | 948 | 7641 | 0.1241 | 0.4502 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.29 | 84.90 | 1091 | 7934 | 0.1375 | 0.4771 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.29 | 84.90 | 1125 | 7934 | 0.1418 | 0.4840 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.29 | 84.90 | 420 | 7934 | 0.0529 | 0.2766 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.29 | 84.90 | 968 | 7934 | 0.1220 | 0.4503 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.99 | 84.90 | 1146 | 8212 | 0.1396 | 0.4838 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.99 | 84.90 | 1184 | 8212 | 0.1442 | 0.4911 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.99 | 84.90 | 417 | 8212 | 0.0508 | 0.2729 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.99 | 84.90 | 946 | 8212 | 0.1152 | 0.4412 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.70 | 84.90 | 1143 | 8484 | 0.1347 | 0.4790 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.70 | 84.90 | 1179 | 8484 | 0.1390 | 0.4860 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.70 | 84.90 | 466 | 8484 | 0.0549 | 0.2922 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.70 | 84.90 | 1200 | 8484 | 0.1414 | 0.4899 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.41 | 84.90 | 1146 | 8766 | 0.1307 | 0.4755 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.41 | 84.90 | 1184 | 8766 | 0.1351 | 0.4828 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.41 | 84.90 | 439 | 8766 | 0.0501 | 0.2784 | MN20160318_Q02 | M17 |